300676 华大基因
2024/09 - 九个月2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)-1.2610.9328.27819.19540.890
总资产报酬率 ROA (%)-0.9230.6645.60611.48624.442
投入资产回报率 ROIC (%)-1.0740.7766.45113.70122.333

边际利润分析
销售毛利率 (%)45.21649.90352.27358.09460.070
营业利润率 (%)-4.2363.46315.42426.94129.750
息税前利润/营业总收入 (%)-6.5871.60114.15527.34431.619
净利润/营业总收入 (%)-4.3942.15411.47421.84025.033

收益指标分析
经营活动净收益/利润总额(%)-4.248206.610115.02096.795104.346
价值变动净收益/利润总额(%)27.962-28.62638.56014.9056.278
营业外收支净额/利润总额(%)5.765-30.392-8.057-4.407-2.288

偿债能力分析
流动比率 (X)2.6322.4062.4713.2612.214
速动比率 (X)2.3842.2232.2903.0021.948
资产负债率 (%)24.94026.51128.94533.76446.175
带息债务/全部投入资本 (%)13.35014.78616.16119.847--
股东权益/带息债务 (%)643.231570.761508.284372.023282.188
股东权益/负债合计 (%)296.635273.186242.000193.619114.331
利息保障倍数 (X)3.149-1.518-118.56117.74512.478

营运能力分析
应收账款周转天数 (天)156.360151.33587.48173.8150.000
存货周转天数 (天)114.887109.04185.318119.8260.000